Literature DB >> 20505142

Constitutive CD40L expression on B cells prematurely terminates germinal center response and leads to augmented plasma cell production in T cell areas.

Anna Bolduc1, Eugene Long, Dale Stapler, Marilia Cascalho, Takeshi Tsubata, Pandelakis A Koni, Michiko Shimoda.   

Abstract

CD40/CD40L engagement is essential to T cell-dependent B cell proliferation and differentiation. However, the precise role of CD40 signaling through cognate T-B interaction in the generation of germinal center and memory B cells is still incompletely understood. To address this issue, a B cell-specific CD40L transgene (CD40LBTg) was introduced into mice with B cell-restricted MHC class II deficiency. Using this mouse model, we show that constitutive CD40L expression on B cells alone could not induce germinal center differentiation of MHC class II-deficient B cells after immunization with T cell-dependent Ag. Thus, some other MHC class II-dependent T cell-derived signals are essential for the generation of germinal center B cells in response to T cell-dependent Ag. In fact, CD40LBTg mice generated a complex Ag-specific IgG1 response, which was greatly enhanced in early, but reduced in late, primary response compared with control mice. We also found that the frequency of Ag-specific germinal center B cells in CD40LBTg mice was abruptly reduced 1 wk after immunization. As a result, the numbers of Ag-specific IgG1 long-lived plasma cells and memory B cells were reduced. By histology, large numbers of Ag-specific plasma cells were found in T cell areas adjacent to Ag-specific germinal centers of CD40LBTg mice, temporarily during the second week of primary response. These results indicate that CD40L expression on B cells prematurely terminated their ongoing germinal center response and produced plasma cells. Our results support the notion that CD40 signaling is an active termination signal for germinal center reaction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20505142      PMCID: PMC3708602          DOI: 10.4049/jimmunol.0901689

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

1.  B cell immunopoiesis: visualizing the impact of CD40 engagement on the course of T cell-independent immune responses in an Ig transgenic system.

Authors:  L D Erickson; L A Vogel; M Cascalho; J Wong; M Wabl; B G Durell; R J Noelle
Journal:  Eur J Immunol       Date:  2000-11       Impact factor: 5.532

2.  Short-circuiting long-lived humoral immunity by the heightened engagement of CD40.

Authors:  Loren D Erickson; Brigit G Durell; Laura A Vogel; Brian P O'Connor; Marilia Cascalho; Teruhito Yasui; Hitoshi Kikutani; Randolph J Noelle
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  A conditional null allele of the major histocompatibility IA-beta chain gene.

Authors:  Kahoko Hashimoto; Sunil K Joshi; Pandelakis A Koni
Journal:  Genesis       Date:  2002-02       Impact factor: 2.487

4.  Platelet-derived CD40L: the switch-hitting player of cardiovascular disease.

Authors:  Patrick André; Lisa Nannizzi-Alaimo; Srinivasa K Prasad; David R Phillips
Journal:  Circulation       Date:  2002-08-20       Impact factor: 29.690

5.  Cutting Edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease.

Authors:  Tetsuya Higuchi; Yuichi Aiba; Takashi Nomura; Junichiro Matsuda; Keiji Mochida; Misao Suzuki; Hitoshi Kikutani; Tasuku Honjo; Kiyoshi Nishioka; Takeshi Tsubata
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

6.  Cutting edge: critical role of inducible costimulator in germinal center reactions.

Authors:  C Dong; U A Temann; R A Flavell
Journal:  J Immunol       Date:  2001-03-15       Impact factor: 5.422

7.  CD40 regulates the processing of NF-kappaB2 p100 to p52.

Authors:  H J Coope; P G P Atkinson; B Huhse; M Belich; J Janzen; M J Holman; G G B Klaus; L H Johnston; S C Ley
Journal:  EMBO J       Date:  2002-10-15       Impact factor: 11.598

8.  Th2-dependent B cell responses in the absence of CD40-CD40 ligand interactions.

Authors:  N Chirmule; J Tazelaar; J M Wilson
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

9.  Germinal centers without T cells.

Authors:  C G de Vinuesa; M C Cook; J Ball; M Drew; Y Sunners; M Cascalho; M Wabl; G G Klaus; I C MacLennan
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

10.  Conditional vascular cell adhesion molecule 1 deletion in mice: impaired lymphocyte migration to bone marrow.

Authors:  P A Koni; S K Joshi; U A Temann; D Olson; L Burkly; R A Flavell
Journal:  J Exp Med       Date:  2001-03-19       Impact factor: 14.307

View more
  22 in total

1.  CD40L-null NKT cells provide B cell help for specific antibody responses.

Authors:  Hemangi B Shah; Sunil K Joshi; Mark L Lang
Journal:  Vaccine       Date:  2011-09-28       Impact factor: 3.641

2.  Reduction of CD1d expression in vivo minimally affects NKT-enhanced antibody production but boosts B-cell memory.

Authors:  Gillian A Lang; Amy M Johnson; T Scott Devera; Sunil K Joshi; Mark L Lang
Journal:  Int Immunol       Date:  2011-03-12       Impact factor: 4.823

3.  Rate of Immune Complex Cycling in Follicular Dendritic Cells Determines the Extent of Protecting Antigen Integrity and Availability to Germinal Center B Cells.

Authors:  Theinmozhi Arulraj; Sebastian C Binder; Michael Meyer-Hermann
Journal:  J Immunol       Date:  2021-02-19       Impact factor: 5.422

4.  Cyclosporine-resistant, Rab27a-independent mobilization of intracellular preformed CD40 ligand mediates antigen-specific T cell help in vitro.

Authors:  Yoshinobu Koguchi; Jennifer L Gardell; Timothy J Thauland; David C Parker
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

Review 5.  T follicular helper cells, T follicular regulatory cells and autoimmunity.

Authors:  Yangyang Zhu; Le Zou; Yun-Cai Liu
Journal:  Int Immunol       Date:  2015-12-29       Impact factor: 4.823

6.  Constitutive canonical NF-κB activation cooperates with disruption of BLIMP1 in the pathogenesis of activated B cell-like diffuse large cell lymphoma.

Authors:  Dinis Pedro Calado; Baochun Zhang; Lakshmi Srinivasan; Yoshiteru Sasaki; Jane Seagal; Christine Unitt; Scott Rodig; Jeffery Kutok; Alexander Tarakhovsky; Marc Schmidt-Supprian; Klaus Rajewsky
Journal:  Cancer Cell       Date:  2010-12-14       Impact factor: 31.743

7.  B cells from African American lupus patients exhibit an activated phenotype.

Authors:  Laurence C Menard; Sium Habte; Waldemar Gonsiorek; Deborah Lee; Dana Banas; Deborah A Holloway; Nataly Manjarrez-Orduno; Mark Cunningham; Dawn Stetsko; Francesca Casano; Selena Kansal; Patricia M Davis; Julie Carman; Clarence K Zhang; Ferva Abidi; Richard Furie; Steven G Nadler; Suzanne J Suchard
Journal:  JCI Insight       Date:  2016-06-16

8.  Constitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 induction.

Authors:  Pandelakis A Koni; Anna Bolduc; Mayuko Takezaki; Yutetsu Ametani; Lei Huang; Jeffrey R Lee; Stephen L Nutt; Masahito Kamanaka; Richard A Flavell; Andrew L Mellor; Takeshi Tsubata; Michiko Shimoda
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

Review 9.  Design of vaccine adjuvants incorporating TNF superfamily ligands and TNF superfamily molecular mimics.

Authors:  Sachin Gupta; James M Termini; Saravana Kanagavelu; Geoffrey W Stone
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

10.  The intestinal B-cell response in celiac disease.

Authors:  Luka Mesin; Ludvig M Sollid; Roberto Di Niro
Journal:  Front Immunol       Date:  2012-10-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.